Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,591
Closed -$82K 1736
2025
Q3
$82K Hold
5,591
﹤0.01% 1382
2025
Q2
$55K Buy
+5,591
New +$46.3K ﹤0.01% 1560

Other funds holding ETNB

KBC Group's ETNB Position: Q4 2025 in Review

KBC Group sold out of 89bio (ETNB) in Q4 2025, closing a stake of 5,591 shares — an estimated $82K sold.

KBC Group first reported a position in ETNB in Q2 2025 and held it in 2 quarters. The position peaked at $82K in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • KBC Group reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • KBC Group sold 5,591 89bio shares in Q4 2025, an estimated $82K.
  • KBC Group first reported a position in 89bio in Q2 2025 and held it in 2 quarters.
  • KBC Group's 89bio position peaked at $82K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on KBC Group's 13F filing for Q4 2025, filed 26 Jan 2026.